Literature DB >> 6959130

Isolation and characterization of a cDNA coding for human factor IX.

K Kurachi, E W Davie.   

Abstract

A cDNA library prepared from human liver has been screened for factor IX (Christmas factor), a clotting factor that participates in the middle phase of blood coagulation. The library was screened with a single-stranded DNA prepared from enriched mRNA for baboon factor IX and a synthetic oligonucleotide mixture. A plasmid was identified that contained a cDNA insert of 1,466 base pairs coding for human factor IX. The insert is flanked by G-C tails of 11 and 18 base pairs at the 5' and 3' ends, respectively. It also included 138 base pairs that code for an amino-terminal leader sequence, 1,248 base pairs that code for the mature protein, a stop codon, and 48 base pairs of noncoding sequence at the 3' end. The leader sequence contains 46 amino acid residues, and it is proposed that this sequence includes both a signal sequence and a pro sequence for the mature protein that circulates in plasma. The 1,248 base pairs code for a polypeptide chain composed of 416 amino acids. The amino-terminal region for this protein contains 12 glutamic acid residues that are converted to gamma-carboxyglutamic acid in the mature protein. These glutamic acid residues are coded for by both GAA and GAG. The arginyl peptide bonds that are cleaved in the conversion of human factor IX to factor IXa by factor XIa were identified as Arg145-Ala146 and Arg180-Val181. The cleavage of these two internal peptide bonds results in the formation of an activation peptide (35 amino acids) and factor IXa, a serine protease composed of a light chain (145 amino acids) and a heavy chain (236 amino acids), and these two chains are held together by a disulfide bond(s). The active site residues including histidine, aspartate, and serine are located in the heavy chain at positions 221, 270, and 366, respectively. These amino acids are homologous with His57, Asp102, and Ser195 in the active site of chymotrypsin. Two potential carbohydrate binding sites (Asn-X-Thr) were identified in the activation peptide, and these were located at Asn157 and Asn167. The homology in the amino acid sequence between human and bovine factor IX was found to be 83%.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6959130      PMCID: PMC347146          DOI: 10.1073/pnas.79.21.6461

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent).

Authors:  K Fujikawa; M E Legaz; H Kato; E W Davie
Journal:  Biochemistry       Date:  1974-10-22       Impact factor: 3.162

2.  Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact region.

Authors:  A Rühlmann; D Kukla; P Schwager; K Bartels; R Huber
Journal:  J Mol Biol       Date:  1973-07-05       Impact factor: 5.469

3.  Isolation and characterization of bovine factor IX (Christmas factor).

Authors:  K Fujikawa; A R Thompson; M E Legaz; R G Meyer; E W Davie
Journal:  Biochemistry       Date:  1973-11-20       Impact factor: 3.162

4.  Structure of crystalline -chymotrypsin. II. A preliminary report including a hypothesis for the activation mechanism.

Authors:  P B Sigler; D M Blow; B W Matthews; R Henderson
Journal:  J Mol Biol       Date:  1968-07-14       Impact factor: 5.469

5.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

6.  3' non-coding region sequences in eukaryotic messenger RNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

7.  Further procedures for sequence analysis by computer.

Authors:  R Staden
Journal:  Nucleic Acids Res       Date:  1978-03       Impact factor: 16.971

8.  Sequence data handling by computer.

Authors:  R Staden
Journal:  Nucleic Acids Res       Date:  1977-11       Impact factor: 16.971

9.  A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S.

Authors:  R G Di Scipio; M A Hermodson; S G Yates; E W Davie
Journal:  Biochemistry       Date:  1977-02-22       Impact factor: 3.162

10.  Bovine microsomal albumin: amino terminal sequence of bovine proalbumin.

Authors:  J E Patterson; D M Geller
Journal:  Biochem Biophys Res Commun       Date:  1977-02-07       Impact factor: 3.575

View more
  87 in total

1.  Identification of two novel transmembrane gamma-carboxyglutamic acid proteins expressed broadly in fetal and adult tissues.

Authors:  J D Kulman; J E Harris; L Xie; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  Replacement therapy with recombinant factor IX. A multicentre evaluation of current dosing practices in Italy.

Authors:  Alessandra Rocca; Simona Pizzinelli; Emily Oliovecchio; Elena Santagostino; Angiola Rocino; Alfonso Iorio
Journal:  Blood Transfus       Date:  2010-04-30       Impact factor: 3.443

3.  Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX.

Authors:  B G Schach; S Yoshitake; E W Davie
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

4.  r-VKORC1 expression in factor IX BHK cells increases the extent of factor IX carboxylation but is limited by saturation of another carboxylation component or by a shift in the rate-limiting step.

Authors:  Kevin W Hallgren; Wen Qian; Anna V Yakubenko; Kurt W Runge; Kathleen L Berkner
Journal:  Biochemistry       Date:  2006-05-02       Impact factor: 3.162

5.  Defining DNA diagnostic tests appropriate or standard clinical care.

Authors:  R V Lebo; G Cunningham; M J Simons; L J Shapiro
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

6.  MspI polymorphic site within the factor IX gene. Localization of the site and an improved method for detection.

Authors:  D L Freedenberg; S H Chen; K Kurachi; C R Scott
Journal:  Hum Genet       Date:  1987-07       Impact factor: 4.132

7.  gamma -Glutamyl carboxylation: An extracellular posttranslational modification that antedates the divergence of molluscs, arthropods, and chordates.

Authors:  Pradip K Bandyopadhyay; James E Garrett; Reshma P Shetty; Tyler Keate; Craig S Walker; Baldomero M Olivera
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

8.  Gene deletion in an Italian haemophilia B subject.

Authors:  F Bernardi; L del Senno; R Barbieri; D Buzzoni; R Gambari; G Marchetti; F Conconi; F Panicucci; M Positano; S Pitruzzello
Journal:  J Med Genet       Date:  1985-08       Impact factor: 6.318

9.  Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milk.

Authors:  Geun-Cheol Gil; William H Velander; Kevin E Van Cott
Journal:  Glycobiology       Date:  2008-05-02       Impact factor: 4.313

10.  Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene.

Authors:  L Grunebaum; J P Cazenave; G Camerino; C Kloepfer; J L Mandel; P Tolstoshev; M Jaye; H De la Salle; J P Lecocq
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.